Soragni, E., Xu, C., Plasterer, H. L., Jacques, V., Rusche, J. R., & Gottesfeld, J. M. (2012). Rationale for the Development of 2-Aminobenzamide Histone Deacetylase Inhibitors as Therapeutics for Friedreich Ataxia.
Citação norma ChicagoSoragni, Elisabetta, Chunping Xu, Heather L. Plasterer, Vincent Jacques, James R. Rusche, and Joel M. Gottesfeld. Rationale for the Development of 2-Aminobenzamide Histone Deacetylase Inhibitors As Therapeutics for Friedreich Ataxia. 2012.
MLA citiranjeSoragni, Elisabetta, et al. Rationale for the Development of 2-Aminobenzamide Histone Deacetylase Inhibitors As Therapeutics for Friedreich Ataxia. 2012.
Opozorilo: Ti citati niso vedno 100% točni.